CTDX FIRST
Agilent Technologies, Inc.
Mark For: CTDX FIRST® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97116712 |
| Registration Number | 1638461 |
| Mark Literal Elements | CTDX FIRST |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2022-06-22 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Andrew A. Roppel |
| Attorney Docket Number | 128450.4681 |
Timeline
| 2021-11-09 | Application Filed |
| 2021-11-12 | Location: NEW APPLICATION PROCESSING |
| 2021-11-12 | Status: Live/Pending |
| 2021-11-12 | Transaction Date |
| 2022-06-22 | Location: PUBLICATION AND ISSUE SECTION |
| 2022-07-26 | Published |
| 2022-07-26 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
Trademark Parties (Applicants & Owners)
| Party: |  Agilent Technologies, Inc. |
| Address | 5301 Stevens Creek Boulevard Santa Clara, CALIFORNIA UNITED STATES 95051 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | 2021-11-09 | |
| Drawing | 2021-11-09 | |
| Change Address or Representation Form | 2022-02-23 | |
| XSearch Search Summary | 2022-05-23 | |
| Examiners Amendment | 2022-05-25 | |
| Notation to File | 2022-05-25 | |
| Amendment and Mail Process Complete | 2022-05-26 | |
| TRAM Snapshot of App at Pub for Oppostn | 2022-06-23 | |
| Notice of Publication | 2022-07-06 | |
| Notification Of Notice of Publication | 2022-07-06 | |
| OG Publication Confirmation | 2022-07-26 |
Attorney of Record
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: Medical diagnostic reagents and assays for testing of body fluids; Diagnostic kits comprised of medical diagnostic reagents and assays for cancer detection, monitoring and therapy selection; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in cancer detection, monitoring and therapy selection
IC 010. US 026 039 044. G & S: Blood collection kit comprised of blood collecting tubes and vials
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Medical diagnostic reagents and assays; Diagnostic kits comprised of medical diagnostic reagents and assays for cancer detection, monitoring and therapy selection; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in cancer detection, monitoring and therapy selection |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| PUBLISHED FOR OPPOSITION | 2022-07-26 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-07-26 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-07-06 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-06-22 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-05-25 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2022-05-25 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2022-05-25 | 92993 |
| EXAMINER'S AMENDMENT ENTERED | 2022-05-25 | 88888 |
| ASSIGNED TO EXAMINER | 2022-05-18 | 92993 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-02-23 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-02-23 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-02-23 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-02-23 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-02-23 | 88888 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-11-17 | |
| NEW APPLICATION ENTERED IN TRAM | 2021-11-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 